Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies

doi:10.3748/wjg.v17.i46.5059

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5183)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

466

HTML

4364

Figures (1-4)

197

Tables (1-4)

156

Sum=5183

Dec 14, 2011 (publication date) through May 20, 2024

Times Cited of This Article

Times Cited (45)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 14, 2011; 17(46): 5059-5074
Published online Dec 14, 2011. doi: 10.3748/wjg.v17.i46.5059

Open in New Tab Full Size Figure Download Figure

Figure 1 (¹⁸F) 2-fluoro-2-deoxyglucose-positron emission tomography/computed tomography image of a patient with a proximal gastric cancer and occult liver metastasis. The liver lesion was not identified on the corresponding staging computed tomography.

Open in New Tab Full Size Figure Download Figure

Figure 2 (¹⁸F) 2-fluoro-2-deoxyglucose-positron emission tomography/computed tomography detects diffuse bony metastases not seen on staging computed tomography.

Open in New Tab Full Size Figure Download Figure

Figure 3 (¹⁸F) 2-fluoro-2-deoxyglucose-positron emission tomography response in a patient with a proximal gastric cancer receiving chemotherapy.

Open in New Tab Full Size Figure Download Figure

Figure 4 Sensitivity of (¹⁸F) 2-fluoro-2-deoxyglucose-positron emission tomography to identify primary early and advanced gastric carcinoma. FDG-PET: (¹⁸F) 2-fluoro-2-deoxyglucose-positron emission tomography; EGC: Early gastric cancer; AGC: Advanced gastric cancer; CI: Confidence interval.

Citation: Smyth EC, Shah MA. Role of (¹⁸F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol 2011; 17(46): 5059-5074
URL: https://www.wjgnet.com/1007-9327/full/v17/i46/5059.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i46.5059